Skip to main content

and
  1. Article

    Open Access

    Systemic immune inflammation index and system inflammation response index are potential biomarkers of atrial fibrillation among the patients presenting with ischemic stroke

    Chronic inflammatory disorders in atrial fibrillation (AF) contribute to the onset of ischemic stroke. Systemic immune inflammation index (SIII) and system inflammation response index (SIRI) are the two novel ...

    Kai-bin Lin, Feng-hua Fan, Ming-qi Cai, Yin Yu in European Journal of Medical Research (2022)

  2. No Access

    Article

    Multidimensional fatigue in patients with nasopharyngeal carcinoma receiving concurrent chemoradiotherapy: incidence, severity, and risk factors

    To explore the incidence, severity, and risk factors of multidimensional fatigue in patients with nasopharyngeal carcinoma (NPC) receiving concurrent chemoradiotherapy (CCRT).

    Lin-Min Chen, Qiu-Lan Yang, Yu-Yu Duan, Xue-Zhen Huan, Yan He in Supportive Care in Cancer (2021)

  3. No Access

    Article

    A gene-expression-based signature predicts survival in adults with T-cell lymphoblastic lymphoma: a multicenter study

    We aimed to establish a discriminative gene-expression-based classifier to predict survival outcomes of T-cell lymphoblastic lymphoma (T-LBL) patients. After exploring global gene-expression profiles of progre...

    **ao-Peng Tian, Dan **e, Wei-Juan Huang, Shu-Yun Ma, Liang Wang, Yan-Hui Liu in Leukemia (2020)

  4. No Access

    Article

    Upfront autologous stem cell transplantation for untreated diffuse large B cell lymphoma patients in rituximab era: a systematic review and meta-analysis

    To assess the survival outcomes and adverse events (AEs) of high-intermediate- or high-risk patients with diffuse large B cell lymphoma (DLBCL) who underwent conventional chemotherapy plus rituximab with or wi...

    Shu-Yun Ma, **ao-Peng Tian, Jun Cai, Guang-Zheng Zhong, Xu Chen in Annals of Hematology (2020)

  5. No Access

    Article

    Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study

    PEG-rhG-CSF reduces neutropenia and improves chemotherapy safety. In China’s registration trial (CFDA: 2006L01305), we assessed its efficacy and safety against rhG-CSF, and prospectively explored its value ove...

    Jie **e, Jun Cao, **g-fen Wang, Bai-hong Zhang in Breast Cancer Research and Treatment (2018)

  6. No Access

    Article

    Prognostic Significance of Sarcomatous Change in Patients with Hepatocellular Carcinoma After Surgical Resection

    Hepatocellular carcinoma (HCC) with sarcomatous change (SC) is a rare malignancy associated with high aggressiveness and poor prognosis; however, its prognostic significance remains unclear.

    Jiong Lu MD, **an-Ze **ong MD, Fu-Yu Li MD, Hui Ye MD in Annals of Surgical Oncology (2015)

  7. Article

    Erratum to: Comparison of five cisplatin-based regimens frequently used as the first-line protocols in metastatic nasopharyngeal carcinoma

    Ying **, Yan-**a Shi, **u-Yu Cai, **-Ya **a in Journal of Cancer Research and Clinical On… (2015)

  8. No Access

    Article

    Decreased expression of light chain 3 (LC3) increased the risk of distant metastasis in triple-negative breast cancer

    The aim of this study was to evaluate the prognostic value of light chain 3 (LC3) expression in triple-negative breast cancer (TNBC) and describe the association of LC3 expression with the occurrence of metast...

    Jie-Hua He, Rong-Zhen Luo, Mu-Yan Cai, Mei Li, Jia-Bing Lu in Medical Oncology (2013)

  9. No Access

    Article

    Comparison of five cisplatin-based regimens frequently used as the first-line protocols in metastatic nasopharyngeal carcinoma

    No randomized trial has been reported comparing different chemotherapy regimens on disseminated nasopharyngeal carcinoma (NPC). This study aims to compare five cisplatin-based regimens including cisplatin + 5-...

    Ying **, **u-Yu Cai, Yan-**a Shi, **-Ya **a in Journal of Cancer Research and Clinical On… (2012)

  10. No Access

    Article

    Comparison of clinicopathological characteristics and prognoses between bilateral and unilateral breast cancer

    The clinical significance of bilateral breast cancer is unclear and its influence on prognosis is controversial. We compared the characteristics and prognosis of bilateral breast cancer and unilateral breast c...

    Yan-**a Shi, Qing **a, Rou-Jun Peng in Journal of Cancer Research and Clinical On… (2012)

  11. No Access

    Article

    Comparison of overall survival between the early use and delayed use of Trastuzumab therapy groups: a retrospective analysis of 128 patients with HER-2-positive advanced breast cancer

    Trastuzumab has been the standard treatment in first-line treatment of HER-2-positive advanced breast cancer (H2ABC). This study explored whether the delayed and repeated use of trastuzumab could influence ove...

    Yan-**a Shi, Yu-Ting Tan, Zhong-Yu Yuan, Shu-Sen Wang, Rou-Jun Peng in Medical Oncology (2012)

  12. No Access

    Article

    Role of decay-accelerating factor in regulating survival of human cervical cancer cells

    Decay-accelerating factor (DAF) is one of the key molecules involved in cell protection against autologous complement, which restricts the action of complement at critical stages of the cascade reaction. The e...

    Ling-Juan Gao, Lan Ding, Shu-Yu Guo in Journal of Cancer Research and Clinical On… (2011)

  13. No Access

    Article

    Three isoforms of annexin I are preferentially expressed in normal esophageal epithelia but down-regulated in esophageal squamous cell carcinomas

    The development and progression of human cancer are believed to be due to the alterations of multiple genes or/and their protein products. For identifying the proteins associated with esophageal cancer, we ana...

    Shu-Hua **a, Li-** Hu, Hai Hu, Wan-Tao Ying, **n Xu, Yan Cai, Ya-Ling Han in Oncogene (2002)